Key Findings
Ajinomoto Co. has made a strategic investment in Next New World Inc., a startup dedicated to the research, development, and commercialization of silk-derived functional materials, with a particular focus on pet healthcare products. This move aims to expand Ajinomoto’s amino science-based functional materials business and venture into new application sectors, accelerating the provision of innovative solutions to the pet healthcare market.
Technical / Clinical Details
Next New World Inc. centers its technology on silk-derived functional proteins that possess excellent adsorption properties. These proteins are highly biocompatible and can efficiently adsorb specific substances, making them suitable for a wide range of applications. In the pet healthcare sector, they are being developed for daily care products addressing skin issues, maintaining digestive health, and odor control. For instance, products like gentle shampoos and conditioners for pets, or supplements to reduce body odor, are under development, directly targeting common concerns of pet owners. The adsorption characteristics of silk proteins are expected to effectively remove allergens and unwanted chemicals while providing additional benefits such as moisturizing the skin and coat.
Ajinomoto Group plans to combine its deep expertise in amino science with Next New World’s silk protein technology to develop products that are both high-functional and highly safe. This synergy is expected to enhance product performance and optimize manufacturing processes for scalability. In the long term, the companies are exploring applications beyond pet healthcare, aiming for broader market growth in other biomaterial sectors.
Background & Context
In recent years, pets are increasingly regarded as family members, leading to a surge in concern for their health and quality of life (QOL). Consequently, the pet healthcare market has experienced sustained growth, with rising demand for more natural, safe, and effective products. Concerns regarding allergies and chemical exposure have particularly amplified expectations for bio-based functional materials. Ajinomoto Group, leveraging its accumulated amino science knowledge, has expanded its business beyond food to include healthcare, beauty, and functional materials. This investment signifies the group’s focus on biomaterials and the pet healthcare market as new growth drivers and is part of its strategy to strengthen its business portfolio through open innovation.
Strategic Significance & Outlook
The investment in Next New World Inc. represents a critical step for Ajinomoto Group to make a significant entry into the pet healthcare market and accelerate the commercialization of silk-derived functional materials. The plan is to expand the product lineup through joint R&D, introducing high-quality products that meet the specific needs of pets and their owners. This initiative is expected to broaden the choices available for pet healthcare products and contribute to overall industry quality improvement, while also establishing new revenue streams for Ajinomoto Group’s functional materials business. Furthermore, there is potential for applying this silk-derived technology to human-centric products in the future, promising further business expansion.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments